Approvals/CIMA-AEMPS/SERETIDE ACCUHALER 50 MICROGRAMOS/250 MICROGRAMOS/INHALACIÓN, POLVO PARA INHALACIÓN.

Approved

STANDARD

SERETIDE ACCUHALER 50 MICROGRAMOS/250 MICROGRAMOS/INHALACIÓN, POLVO PARA INHALACIÓN.

Glaxosmithkline (Ireland) Limited🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 1e076a2de301e2f6
Drug Cima Aemps Name: SERETIDE ACCUHALER 50 MICROGRAMOS/250 MICROGRAMOS/INHALACIÓN, POLVO PARA INHALACIÓN.
Register Number: 8325IP
Holder Company Name: Glaxosmithkline (Ireland) Limited
Marketing Company Name: Difarmed S.L.U.
Holder Company Detail Path: /organization/glaxosmithkline-ireland-limited
Authorization Date: 2023-11-03
Dosage Form: POLVO PARA INHALACIÓN
Dose: 50/250 mcg
Route Of Administration: VÍA INHALATORIA
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: Yes
Company Name: Glaxosmithkline (Ireland) Limited
Company Detail Path: /organization/glaxosmithkline-ireland-limited

FLUTICASONA PROPIONATO

231 µg

SALMETEROL XINAFOATO

47 µg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Nov 3, 2023

Approval ID

1e076a2de301e2f6

Type

Standard